Status:
RECRUITING
Non-invasive Point-Of-Care Hemoglobin Testing In An Obstetric Population
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Pregnancy Anemia
Eligibility:
FEMALE
18-60 years
Brief Summary
Anemia is common during pregnancy due to increased metabolic rate and normal physiologic changes associated with pregnancy. Anemia during pregnancy has been associated with increased of adverse outcom...
Detailed Description
This is a prospective observational study of a non-invasive hemoglobin measurement device in a pregnant patient population. The device is FDA approved for use in adults, children, and neonates. The cu...
Eligibility Criteria
Inclusion
- Pregnant or postpartum;
- Age ≥18 years old;
- Undergoing phlebotomy for clinical purpose
Exclusion
- \- None
Key Trial Info
Start Date :
December 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06521840
Start Date
December 1 2024
End Date
August 1 2026
Last Update
January 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02115